Tenet Healthcare (FRA:THC1) Other Financing: €-1,245 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:THC1 Tenet Healthcare Corp FRA:THC1
78 GF Score
Price €220.00
GF Value €158.32
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Tenet Healthcare Other Financing?

Tenet Healthcare FRA:THC1 -1.79% 78 Other Financing is €-1,245 Mil as of Jun. 2026. GuruFocus rates FRA:THC1 with a GF Score™ of 78/100 and a GF Value™ of €158.32 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Tenet Healthcare's Other Financing for the three months ended in Jun. 2026 was €-109 Mil.

Tenet Healthcare's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was €-1,245 Mil.

Tenet Healthcare Other Financing Historical Data

* Premium members only.

The historical data trend for Tenet Healthcare's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tenet Healthcare Other Financing Chart

Tenet Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -519.50 -663.63 -607.97 -757.32 -784.83

Tenet Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -202.01 -177.22 -178.49 -781.10 -108.50
FRA:THC1
78GF Score
Tenet Healthcare Corp FRA:THC1
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tenet Healthcare Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1,245 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €-1,245 Mil mean?
Tenet Healthcare (FRA:THC1) has a Other Financing of €-1,245 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Tenet Healthcare and its competitors.
Is Tenet Healthcare's Other Financing too high?
Tenet Healthcare's current Other Financing is €-1,245 Mil. Overall, Tenet Healthcare has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tenet Healthcare's Other Financing compare to DVA and EHC?
Tenet Healthcare's Other Financing of €-1,245 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Tenet Healthcare and its competitors. Tenet Healthcare's current Other Financing is €-1,245 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenet Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Tenet Healthcare (FRA:THC1) is currently considered Significantly Overvalued. The stock's GF Value™ is €158.32, compared to a current price of €220.00 — trading 39% above its estimated fair value. The current Other Financing is €-1,245 Mil. Tenet Healthcare's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Tenet Healthcare (FRA:THC1), the current Other Financing is €-1,245 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tenet Healthcare (FRA:THC1) Overvalued in 2026?

Based on GuruFocus' analysis, Tenet Healthcare stock appears to be overvalued. The current stock price of €220.00 is trading 39% above its estimated GF Value™ of €158.32. GuruFocus considers Tenet Healthcare to be Significantly Overvalued.

Key valuation signals for FRA:THC1:

  • Other Financing: €-1,245 Mil
  • GF Value™: €158.32 vs. price of €220.00 (39% above fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the FRA:THC1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tenet Healthcare Business Description

Other Exchanges THC:USA1THC:Italy
Address 14201 Dallas Parkway, Dallas, TX, USA, 75254
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
78GF Score

Get the complete analysis for FRA:THC1

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€220.00
Price
€158.32
GF Value